Nivolumab

10 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)

Phase 2(9)

Drug	Company
BMS-986249	CytomX Therapeutics, Inc. (CTMX)
Cabozantinib	PTC THERAPEUTICS, INC. (PTCT)
Daratumumab	PTC THERAPEUTICS, INC. (PTCT)
Enzalutamide	PTC THERAPEUTICS, INC. (PTCT)
PYX-107	Pyxis Oncology, Inc. (PYXS)
Regorafinib	PTC THERAPEUTICS, INC. (PTCT)
Relatlimab	PTC THERAPEUTICS, INC. (PTCT)
Rucaparib	PTC THERAPEUTICS, INC. (PTCT)
Trametinib	PTC THERAPEUTICS, INC. (PTCT)

BioSniper tracks 10 drugs in development for Nivolumab across 4 companies.

There are 1 clinical trial targeting Nivolumab tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.